21-Nov-2024 14:54 |
131.20p |
5,747 |
£7,540 |
Sell |
O |
21-Nov-2024 08:50 |
128.88p |
5,083 |
£6,551 |
Sell |
O |
21-Nov-2024 10:35 |
128.88p |
1,543 |
£1,989 |
Sell |
O |
21-Nov-2024 08:37 |
127.00p |
1,300 |
£1,651 |
Sell |
O |
21-Nov-2024 08:37 |
127.00p |
1,300 |
£1,651 |
Sell |
O |
21-Nov-2024 08:52 |
128.88p |
1,277 |
£1,646 |
Sell |
O |
21-Nov-2024 08:37 |
127.00p |
842 |
£1,069 |
Buy |
AT |
21-Nov-2024 11:31 |
131.46p |
760 |
£999 |
Buy |
O |
21-Nov-2024 08:37 |
127.00p |
559 |
£710 |
Buy |
AT |
21-Nov-2024 14:31 |
131.00p |
450 |
£590 |
Sell |
AT |
21-Nov-2024 11:44 |
132.90p |
21 |
£28 |
Buy |
O |
14:54 |
5,747 @ 131.20p |
14:31 |
450 @ 131.00p |
11:44 |
21 @ 132.90p |
11:31 |
760 @ 131.46p |
10:35 |
1,543 @ 128.88p |
CEO |
Alexander William Solomou |
CFO |
Richard Jarvis |
Top of Page
You are here:
research